In this study, we further characterized the immunostimulatory properties of this CpG-2722 and investigated its tumor-suppressive activities alone and in combination with anti-PD-1 using this developed orthotopic syngeneic HNSCC animal model. The gene discussed is PDCD1; the disease is neoplasm.